Sept 29 (Reuters) – Jiangsu Nhwa Pharmaceutical Co Ltd : * SAYS CO SIGNED EXCLUSIVE LICENSING DEAL WITH SOMNIVERA FOR INVESTIGATIONAL SLEEP DISORDER DRUG * SAYS CO TO RECEIVE $10.5 MILLION UPFRONT
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Deepa Seetharaman SAN FRANCISCO, Sept 29 (Reuters) - Current and former OpenAI and Google…
By Deepa Seetharaman SAN FRANCISCO, Sept 29 (Reuters) - Current and former OpenAI and Google…
Sep 29 (OPTA) - Scoreboard at stumps on the first day of 2nd four-day match…
VIDEO SHOWS: SOUNDBITES FROM NOVAK DJOKOVIC AHEAD OF CHINA OPEN COMPLETE SCRIPT TO FOLLOW SHOWS:…
Sept 29 (Reuters) - Oura has delayed its US initial public offering, the smart ring…
By Manya Saini Sept 29 (Reuters) - Oura has delayed its US initial public offering,…